Aurinia Pharmaceuticals Inc

AUPHNASDAQ · USD
14.70USD0.00 (-1.28%)
757

Aurinia Pharmaceuticals Inc (AUPH) Option Chain

Aurinia Pharmaceuticals Inc trades at $14.70, down 1.28%, with an IV Rank of 61.11%. This is average versus the past year, and the company carries a market cap of $1,970M in the Biotechnology industry. On the Dec 18, 2026 chain, the at the money $15.00 strike shows calls at $0.35 / $0.90 and puts at $0.60 / $1.35, both carrying about $0.65 of extrinsic value. The call has a 57.56% probability of expiring out of the money, and the put has 42.44%. Volume is heaviest on the $16.00 calls, at 105 contracts, and the $15.00 puts, at 20, as of Nov 20, 2026.

Read more

Tracking the AUPH option chain helps you see every strike and expiry on Aurinia Pharmaceuticals Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of AUPH options activity at a glance. Use our scanner to monitor the AUPH option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For AUPH stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where AUPH options are being actively traded, and where they are not.

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

2026-12-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
20.931600.501.701.203.2013.00-11.56—0.950.000.950079.07
38.5410110.980.700.952.4014.00-4.76—0.750.000.750061.46
57.562110.630.000.350.9015.00+2.040.601.350.300.67203242.44
73.9441050.400.00—0.4016.00+8.841.302.301.300.5020226.06
85.667810.650.00—0.6517.00+15.650.903.102.30-0.3001214.34

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank61.11% Moderate
  • Market cap (M$)1,970
  • 52 weeks high-23.64%
  • 52 weeks low8.73%
  • Analyst recommendationBuy
    1.67
  • Target price$18.50
    25.85% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-10-30
  • P/E6.42
  • Future P/E12.67
  • EPS (ttm)2.29
  • EPS growth next 5 years-11.67%

As of Nov 20, 2026